CCT365623 hydrochloride |
| Catalog No.GC39587 |
Le chlorhydrate de CCT365623 est un inhibiteur de la lysyl oxydase (LOX) actif par voie orale, avec une IC50 de 0,89 μM. Le chlorhydrate de CCT365623 supprime l'EGFR (pY1068) et la phosphorylation de l'AKT entraÎnée par l'EGF. Le chlorhydrate de CCT365623 est extrêmement bien toléré et possède de bonnes propriétés pharmacocinétiques.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2126136-98-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor, with an IC50 of 0.89 μM. CCT365623 hydrochloride suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. CCT365623 hydrochloride is extremely well tolerated, and has good pharmacokinetic properties[1].
[1]. Tang H, et al. Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface. Nat Commun. 2019 Jul 18;10(1):3151.
Average Rating: 5 (Based on Reviews and 28 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *